NeuroSense Therapeutics NRSN
NASDAQ NRSN
$6.62 +0.27 (+4.25%)
At close: Sep 21, 2026 · 4:00 PM EDT

NeuroSense Therapeutics (NRSN) Share-based Compensation Growth (1y) (2025)

Analysis

NeuroSense Therapeutics (NRSN) Share-based Compensation Growth (1y) (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (1y) (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn 19.90%
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn 2.67%
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn 71.86%
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn -3.46%
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn -7.69%
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn -
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn -22.43%
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn 3.34%
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn -
10 NeuroSense Therapeutics 8.09 Mn 7.88 Mn - 34.69%
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 34.69%
API Access

NeuroSense Therapeutics Share-based Compensation Growth (1y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-growth-1y&ticker=NRSN&period=max&api_key=YOUR_API_KEY